Menu
GWAS Study

A polygenic risk score for predicting racial and genetic susceptibility to prurigo nodularis.

Vasavda C, Wan G, Szeto MD et al.

37245863 PubMed ID
GWAS Study Type
199049 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VC
Vasavda C
WG
Wan G
SM
Szeto MD
MM
Marani M
SN
Sutaria N
RA
Rajeh A
LC
Lu C
LK
Lee KK
NN
Nguyen NTT
AW
Adawi W
DJ
Deng J
PV
Parthasarathy V
BZ
Bordeaux ZA
TM
Taylor MT
AM
Alphonse MP
KM
Kwatra MM
KS
Kang S
SY
Semenov YR
GA
Gusev A
KS
Kwatra SG
Chapter II

Abstract

Summary of the research findings

Prurigo nodularis (PN) is an understudied inflammatory skin disease characterized by pruritic, hyperkeratotic nodules. Identifying the genetic factors underlying PN could help to better understand its etiology and guide the development of therapies. In this study, we developed a polygenic risk score that predicts a diagnosis of PN (OR = 1.41, P = 1.6 × 10-5) in two independent and continentally distinct populations. We also performed GWASs, which uncovered genetic variants associated with PN, including one near PLCB4 (rs6039266: OR = 3.15, P = 4.8 × 10-8) and others near TXNRD1 (rs34217906: OR = 1.71, P = 6.4 × 10-7; rs7134193: OR = 1.57, P = 1.1 × 10-6). Finally, we discovered that Black patients have over a two-times greater genetic risk of developing PN (OR = 2.63, P = 7.8 × 10-4). Combining the polygenic risk score and self-reported race together was significantly predictive of PN (OR = 1.32, P = 4.7 × 10-3). Strikingly, this association was more significant with race than after adjusting for genetic ancestry. Because race is a sociocultural construct and not a genetically bound category, our findings suggest that genetics, environmental influence, and social determinants of health likely affect the development of PN and may contribute to clinically observed racial disparities.

309 Finnish ancestry cases, 198,740 Finnish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

199049
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.